Skip to main content
NVDA-0.03%AAPL+0.08%GOOGL+1.77%MSFT-0.17%AMZN-0.01%TSM+1.22%SPCX+2.04%AVGO+0.32%META-0.08%TSLA-0.11%SKHY+0.94%MU-0.03%BRK-B+0.66%LLY-0.65%JPM+0.76%WMT+1.34%AMD+2.49%V+0.88%XOM+0.46%ASMLa+0.28%JNJ-0.29%INTC+2.61%MA+0.68%0700.HK+0.66%1398.HK0.00%ABBV+0.83%BAC+0.21%CSCO+4.37%ORCL-1.74%CVX+0.61%COST+0.26%KO+0.52%CAT+1.69%DELL+11.98%LRCX+0.07%AP2d+1.32%AMAT+0.55%HSBA.L+1.54%0005.HK-0.85%PG+1.61%UNH-2.37%MS+0.81%GE-0.15%3988.HK+1.34%1816.HK+0.46%NFLX+1.83%0857.HK-1.09%HD+1.00%GS+0.92%0939.HK-0.20%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%CHFNOK0.00%EURPLN0.00%PLNJPY0.00%NZDCAD0.00%NZDMXN0.00%CHFJPY0.00%CADCHF0.00%EURUSD0.00%EURJPY0.00%GBPAUD0.00%EURCAD0.00%EURNZD0.00%EURNOK0.00%NZDSGD0.00%NZDCHF0.00%EURCZK0.00%AUDCAD0.00%SGDJPY0.00%NOKJPY0.00%NZDUSD0.00%EURGBP0.00%GBPJPY0.00%AUDNZD0.00%AUDSGD0.00%AUDUSD0.00%USDCAD0.00%USDCHF0.00%USDCNH0.00%USDHKD0.00%USDJPY0.00%USDMXN0.00%USDNOK0.00%USDSEK0.00%USDTHB0.00%USDTRY0.00%USDZAR0.00%EURCHF0.00%EURHKD0.00%CADJPY0.00%AUDNOK0.00%EURAUD0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%USDDKK0.00%GBPCHF0.00%GBPUSD0.00%GBPCAD0.00%USDPLN0.00%AUDDKK0.00%CHFSGD0.00%CHFSEK0.00%AUDJPY0.00%AUDCHF0.00%USDSGD0.00%EURDKK0.00%NZDJPY0.00%EURSEK0.00%GBPNZD0.00%GBPSGD0.00%GBPZAR0.00%GAGUSD0.00%HG10.00%S10.00%USOIL0.00%W10.00%XAGUSD0.00%XAUUSD0.00%C10.00%XNGUSD0.00%COCOA0.00%COFFEE0.00%COTTON0.00%BTCUSD+0.04%ETHUSD-0.70%USDTUSD-0.01%XRPUSD-0.67%SOLUSD-0.58%TRXUSDT+0.52%ZECUSDT-2.28%DOGEUSD-0.70%XMRUSDT-0.94%LINKUSD-0.58%XLMUSD-0.14%BCHUSDT-0.83%LTCUSD+2.42%UNIUSD-1.84%TONUSD+23.75%HBARUSDT+1.99%SUIUSD-0.79%TAOUSDT+0.91%AAVEUSD+0.70%DOTUSDT-0.20%ICPUSDT+1.44%ONDOUSDT+0.62%WLDUSDT-1.64%ARBUSDT-2.08%ATOMUSDT-0.11%JUPUSDT-4.21%INJUSDT+1.31%STXUSDT+1.68%FETUSDT+2.51%PYTHUSDT+3.69%TIAUSDT+2.31%SEIUSDT+2.45%IMXUSDT+2.30%GRTUSDT+2.75%WIFUSDT-0.16%OPUSDT+1.85%POLUSDT+0.67%IOTAUSDT+0.98%AXSUSDT+2.17%FARTCOINUSDT+0.26%EOSUSDT+0.65%DYDXUSDT+0.62%ORDIUSDT-2.14%GALAUSDT+1.49%NOTUSDT+2.53%RONINUSDT+2.65%NVDA-0.03%AAPL+0.08%GOOGL+1.77%MSFT-0.17%AMZN-0.01%TSM+1.22%SPCX+2.04%AVGO+0.32%META-0.08%TSLA-0.11%SKHY+0.94%MU-0.03%BRK-B+0.66%LLY-0.65%JPM+0.76%WMT+1.34%AMD+2.49%V+0.88%XOM+0.46%ASMLa+0.28%JNJ-0.29%INTC+2.61%MA+0.68%0700.HK+0.66%1398.HK0.00%ABBV+0.83%BAC+0.21%CSCO+4.37%ORCL-1.74%CVX+0.61%COST+0.26%KO+0.52%CAT+1.69%DELL+11.98%LRCX+0.07%AP2d+1.32%AMAT+0.55%HSBA.L+1.54%0005.HK-0.85%PG+1.61%UNH-2.37%MS+0.81%GE-0.15%3988.HK+1.34%1816.HK+0.46%NFLX+1.83%0857.HK-1.09%HD+1.00%GS+0.92%0939.HK-0.20%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%CHFNOK0.00%EURPLN0.00%PLNJPY0.00%NZDCAD0.00%NZDMXN0.00%CHFJPY0.00%CADCHF0.00%EURUSD0.00%EURJPY0.00%GBPAUD0.00%EURCAD0.00%EURNZD0.00%EURNOK0.00%NZDSGD0.00%NZDCHF0.00%EURCZK0.00%AUDCAD0.00%SGDJPY0.00%NOKJPY0.00%NZDUSD0.00%EURGBP0.00%GBPJPY0.00%AUDNZD0.00%AUDSGD0.00%AUDUSD0.00%USDCAD0.00%USDCHF0.00%USDCNH0.00%USDHKD0.00%USDJPY0.00%USDMXN0.00%USDNOK0.00%USDSEK0.00%USDTHB0.00%USDTRY0.00%USDZAR0.00%EURCHF0.00%EURHKD0.00%CADJPY0.00%AUDNOK0.00%EURAUD0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%USDDKK0.00%GBPCHF0.00%GBPUSD0.00%GBPCAD0.00%USDPLN0.00%AUDDKK0.00%CHFSGD0.00%CHFSEK0.00%AUDJPY0.00%AUDCHF0.00%USDSGD0.00%EURDKK0.00%NZDJPY0.00%EURSEK0.00%GBPNZD0.00%GBPSGD0.00%GBPZAR0.00%GAGUSD0.00%HG10.00%S10.00%USOIL0.00%W10.00%XAGUSD0.00%XAUUSD0.00%C10.00%XNGUSD0.00%COCOA0.00%COFFEE0.00%COTTON0.00%BTCUSD+0.04%ETHUSD-0.70%USDTUSD-0.01%XRPUSD-0.67%SOLUSD-0.58%TRXUSDT+0.52%ZECUSDT-2.28%DOGEUSD-0.70%XMRUSDT-0.94%LINKUSD-0.58%XLMUSD-0.14%BCHUSDT-0.83%LTCUSD+2.42%UNIUSD-1.84%TONUSD+23.75%HBARUSDT+1.99%SUIUSD-0.79%TAOUSDT+0.91%AAVEUSD+0.70%DOTUSDT-0.20%ICPUSDT+1.44%ONDOUSDT+0.62%WLDUSDT-1.64%ARBUSDT-2.08%ATOMUSDT-0.11%JUPUSDT-4.21%INJUSDT+1.31%STXUSDT+1.68%FETUSDT+2.51%PYTHUSDT+3.69%TIAUSDT+2.31%SEIUSDT+2.45%IMXUSDT+2.30%GRTUSDT+2.75%WIFUSDT-0.16%OPUSDT+1.85%POLUSDT+0.67%IOTAUSDT+0.98%AXSUSDT+2.17%FARTCOINUSDT+0.26%EOSUSDT+0.65%DYDXUSDT+0.62%ORDIUSDT-2.14%GALAUSDT+1.49%NOTUSDT+2.53%RONINUSDT+2.65%
CE

CeriBell, Inc. (CBLL)

NASDAQHealthcare

$23.63
+$0.19 (+0.9%)
Market closed

Last close at September 11, 2026 at 20:00 UTC

Open$23.65
Day Range$23.04 - $23.65
Avg. Volume (3M)327.7K
Market Cap$896.5M
52 Week Range
$10.85$25.33
Next EarningsIn 51 daysNov 3, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$28M100%
Gross Profitminus cost of goods$25.9M92%

In plain terms: out of every $100 in revenue, CeriBell, Inc. currently loses $69.

Fundamentals & Financials

Revenue (TTM)
$101.9M
Net Income (TTM)
-$65.9M
EPS (TTM)
-$1.76
ROA (TTM)
-39.67%
Current Ratio
9.18

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+16.3%Q1 2026-$0.36
-33.3%Q2 2026-$0.52
-8.2%Q3 2026-$0.51
Next

Nov 3

in 51 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -8.2%

CeriBell trailed consensus on EPS but topped revenue expectations in the second fiscal quarter of 2026, reported August 10, 2026, as revenue rose 32.5% to about $28.1 million (up from $21.2 million a year ago). Revenue of $28.1 million topped the $27.3 million estimate, +3%, while EPS of -$0.51 trailed the -$0.47 estimate (difference -$0.04) and was down from -$0.38 a year ago. Profitability stayed characterized by high gross margin and deeply negative operating leverage, with gross profit of roughly $25.9 million translating to a gross margin of ~92.3%, while operating income was about -$20.0 million for an operating margin of -71.1%. Net income was roughly -$19.3 million, down 41.2% year over year from -$13.6 million, and operating cash flow was negative at about -$12.9 million. Consensus for the next period calls for EPS of -$0.50 on revenue of $29.2 million.

View full earnings history

About CeriBell, Inc.

CeriBell, Inc. trades on the NASDAQ as CBLL and makes neurodiagnostic equipment for the healthcare market, centered on AI-powered electroencephalography used at the patient's bedside. In FY2025, the company generated $89.1 million in revenue from its platform, accessories, and related devices for immediate diagnosis and treatment of neurological conditions.

Name
CeriBell, Inc.
CEO
Xingjuan Chao
Industry
Healthcare
Year Founded
2014
Employees
327

Today's Snapshot

AI-generated

CBLL closed 0.8% above yesterday's close, while its sector was flat. BTIG analyst reiterated its buy rating on CeriBell and kept its $30 price target.

Trading Volume

Below 10d avg (292.5K)

239K

vs S&P 500 Today

Inline with Market

-0.08%

Updated: September 11, 2026 at 20:31 UTC

Technical Indicators

4 Buy3 Neutral1 Sell
CBLL presents a constructive technical picture as the stock trades at 23.63 and sits essentially at the pivot of 23.61 while remaining above its medium and long-term averages, indicating an underlying uptrend. ADX readings are strong, confirming trend strength, and momentum indicators are supportive with a positive MACD and RSI in the upper range, even though the price is slightly beneath the shortest moving averages. On-balance volume is positive and volatility is modest with an ATR near 0.88, which suggests orderly price action. Technical takeaway: Buy.
All signals
  • EMA (5 indicators)$19.15 - $24.00
    Buy
  • RSI (14)56.06
    Neutral
  • Stochastic %K (14, 3, 3)40.63
    Neutral
  • MACD Level (12, 26)0.87
    Neutral
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.